Changes in Nightingale Health Plc’s Management Team

Nightingale Health Plc | Stock Exchange Release | May 02, 2025 at 16:45:00 EEST

Nightingale Health Plc (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and preventative health has appointed Janna Ranta as Chief Operating Officer and a member of management team. Nightingale Health’s co-founder and management team member Satu Saksman, currently acting as the Chief Operating Officer, has been appointed as Chief Commercial Officer. In her new position, Saksman will take on responsibility of Nightingale Health’s healthcare business in Asia. The healthcare business in other regions continues for the time being to be led by CEO Teemu Suna.

Janna Ranta, a longtime employee, is currently acting as Business Director at Nightingale Health. Ranta has held various positions in sales and business development in the company since 2016.

“The global need for preventative healthcare solutions is clearer than ever, and our strong product-market fit is reflected by the growing customer interest in our technology. To better serve our customers, we are expanding our commercial presence in key international locations where our laboratories are located. While increasing our international efforts, we must ensure that our headquarters provides robust support for global business growth. These changes in the management team mark the beginning of this process, and I am thrilled to welcome Satu Saksman and Janna Ranta to their new roles in management team.” says Teemu Suna, CEO and Founder of Nightingale Health.

The appointments will be effective starting on 2^nd May 2025.

About Nightingale Health
Nightingale Health has developed the world's most advanced health check. Our solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale Health Check can be scaled to entire populations and it can replace many of the current routine disease risk assessments and health screening programs for chronic diseases. Detecting disease risks comprehensively and efficiently allows effective targeting and tracking of health interventions, and better prevention of chronic diseases. Nightingale Health's mission is to build sustainable healthcare and reduce health inequalities. With every sample we help to create a healthier world.

Nightingale Health operates globally with a parent company in Finland and eight subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom. Nightingale Health has customers in more than 34 countries in the healthcare and medical research sectors. The Company's technology is being used in many of the world's leading health initiatives, such as the UK Biobank, and over 600 peer-reviewed publications validate the technology. The company's Series B shares are listed on the Main Market of Nasdaq Helsinki and on the OTCQX International market. Read more: https://nightingalehealth.com/